E-LIB Suche - Ergebnisse für: Damen, Eddy

1

(R)‐PFI‐2 Analogues as Substrates and Inhibitors of Histone..:

Porzberg, Miriam R. B. ; Lenstra, Danny C. ; Damen, Eddy...
ChemMedChem. 18 (2023) 23 - p. , 2023

Link: https://doi.org/10.1002/..

2

Front Cover: (R)‐PFI‐2 Analogues as Substrates and Inhibito..:

Porzberg, Miriam R. B. ; Lenstra, Danny C. ; Damen, Eddy...
ChemMedChem. 18 (2023) 23 - p. , 2023

Link: https://doi.org/10.1002/..

3

Discovery of 2,4-1H-Imidazole Carboxamides as Potent and Se..:

Veerman, Johan J. N. ; Bruseker, Yorik B. ; Damen, Eddy...
ACS Medicinal Chemistry Letters. 12 (2021) 4 - p. 555-562 , 2021

Link: https://doi.org/10.1021/..

4

Development of a 1,2,4-Triazole-Based Lead Tankyrase Inhibi..:

Leenders, Ruben G. G. ; Brinch, Shoshy Alam ; Sowa, Sven T....
Journal of Medicinal Chemistry. 64 (2021) 24 - p. 17936-17949 , 2021

Link: https://doi.org/10.1021/..

5

Preclinical Lead Optimization of a 1,2,4-Triazole Based Tan..:

Waaler, Jo ; Leenders, Ruben G. G. ; Sowa, Sven T....
Journal of Medicinal Chemistry. 63 (2020) 13 - p. 6834-6846 , 2020

Link: https://doi.org/10.1021/..

6

Novel SAR for quinazoline inhibitors of EHMT1 and EHMT2:

Leenders, Ruben ; Zijlmans, Remco ; van Bree, Bart...
Bioorganic & Medicinal Chemistry Letters. 29 (2019) 17 - p. 2516-2524 , 2019

Link: https://doi.org/10.1016/..

7

Structure–Activity Relationship Studies on (R)‐PFI‐2 Analog..:

Lenstra, Danny C. ; Damen, Eddy ; Leenders, Ruben G. G....
ChemMedChem. 13 (2018) 14 - p. 1405-1413 , 2018

Link: https://doi.org/10.1002/..

8

Development of a 1,2,4-Triazole-Based Lead Tankyrase Inhibi..:

Leenders, Ruben G. G ; Brinch, Shoshy Alam ; Sowa, Sven T...
NFR/262613. , 2022

Link: http://hdl.handle.net/10..

9

Discovery of 2,4-1H-Imidazole Carboxamides as Potent and Se..:

Veerman, Johan J. N ; Bruseker, Yorik B ; Damen, Eddy...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040042/. , 2021

Link: http://www.ncbi.nlm.nih...

10

Development of a 1,2,4-Triazole-Based Lead Tankyrase Inhibi..:

Leenders, Ruben G. G ; Brinch, Shoshy Alam ; Sowa, Sven T...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713164/. , 2021

Link: http://www.ncbi.nlm.nih...

11

Preclinical Lead Optimization of a 1,2,4-Triazole Based Tan..:

Waaler, Jo ; Leenders, Ruben G. G ; Sowa, Sven T...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008393/. , 2020

Link: http://www.ncbi.nlm.nih...

12

Preclinical lead optimization of a 1,2,4-triazole based tan..:

Waaler, Jo ; Leenders, Ruben G G ; Sowa, Sven T...
http://urn.nb.no/URN:NBN:no-87214. , 2020

Link: http://hdl.handle.net/10..

13

Development of a 1,2,4-triazole-based lead tankyrase inhibi..:

Krauss, S. (Stefan) ; Leenders, R. G. (Ruben G. G.) ; Brinch, S. A. (Shoshy Alam)... , 2021

Link: http://urn.fi/urn:nbn:fi..

14

Preclinical lead optimization of a 1,2,4-triazole based tan..:

Waaler, J. (Jo) ; Leenders, R. G. (Ruben G. G.) ; Sowa, S. T. (Sven T.)... , 2020

Link: http://urn.fi/urn:nbn:fi..

15

Discovery of 2,4‑1 H ‑Imidazole Carboxamides as Potent and ..:

Johan J. N. Veerman (3034902) ; Yorik B. Bruseker (10223438) ; Eddy Damen (9017717)...
https://figshare.com/articles/journal_contribution/Discovery_of_2_4_1_i_H_i_Imidazole_Carboxamides_as_Potent_and_Selective_TAK1_Inhibitors/14152940. , 2021

Link: https://doi.org/10.1021/..